Adherence to elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis: the Your ETI (yETI) study.

Everhart RS, Ford C, Gibson SL, Riekert KA, Duncan CL, Bord E, Hoppe JE, Lyons E, Prickett M, von Isenburg M, Muther EF

Open source

DOI
10.1093/annalsats/aaoag100
Published
2026 Aug 1
Container
Annals of the American Thoracic Society
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/annalsats/aaoag100,
  title = {Adherence to elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis: the Your ETI (yETI) study.},
  author = {Everhart RS and Ford C and Gibson SL and Riekert KA and Duncan CL and Bord E and Hoppe JE and Lyons E and Prickett M and von Isenburg M and Muther EF},
  year = {2026},
  journal = {Annals of the American Thoracic Society},
  doi = {10.1093/annalsats/aaoag100},
  url = {https://doi.org/10.1093/annalsats/aaoag100}
}

RIS

TY  - JOUR
TI  - Adherence to elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis: the Your ETI (yETI) study.
AU  - Everhart RS
AU  - Ford C
AU  - Gibson SL
AU  - Riekert KA
AU  - Duncan CL
AU  - Bord E
AU  - Hoppe JE
AU  - Lyons E
AU  - Prickett M
AU  - von Isenburg M
AU  - Muther EF
PY  - 2026
JO  - Annals of the American Thoracic Society
DO  - 10.1093/annalsats/aaoag100
UR  - https://doi.org/10.1093/annalsats/aaoag100
ER  - 

APA

RS, E., C, F., SL, G., KA, R., CL, D., E, B., JE, H., E, L., M, P., M, V. I., & EF, M. (2026). Adherence to elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis: the Your ETI (yETI) study.. Annals of the American Thoracic Society. https://doi.org/10.1093/annalsats/aaoag100

Source records